Katherine E. Olson

1.5k total citations
25 papers, 999 citations indexed

About

Katherine E. Olson is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Katherine E. Olson has authored 25 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 15 papers in Neurology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Katherine E. Olson's work include Neuroinflammation and Neurodegeneration Mechanisms (19 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Nerve injury and regeneration (6 papers). Katherine E. Olson is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (19 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Nerve injury and regeneration (6 papers). Katherine E. Olson collaborates with scholars based in United States, Egypt and China. Katherine E. Olson's co-authors include Howard E. Gendelman, R. Lee Mosley, Jatin Machhi, Krista L. Namminga, Yaman Lu, Mai Mohamed Abdelmoaty, Bhavesh D. Kevadiya, Jonathan Herskovitz, Lisa M. Kosloski and Elizabeth A. Kosmacek and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Biomaterials.

In The Last Decade

Katherine E. Olson

25 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katherine E. Olson United States	19	578	372	272	244	209	25	999
Yaman Lu United States	17	382 0.7×	189 0.5×	176 0.6×	245 1.0×	173 0.8×	25	781
Pritha Sen United States	8	801 1.4×	197 0.5×	159 0.6×	310 1.3×	451 2.2×	14	1.4k
Mathias Linnerbauer Germany	11	624 1.1×	127 0.3×	163 0.6×	222 0.9×	386 1.8×	15	1.2k
Eduardo A. Albornoz Australia	10	359 0.6×	257 0.7×	114 0.4×	179 0.7×	517 2.5×	18	992
Ashley D. Reynolds United States	10	877 1.5×	711 1.9×	532 2.0×	280 1.1×	212 1.0×	10	1.3k
Susanna Mantovani Australia	13	410 0.7×	349 0.9×	166 0.6×	201 0.8×	606 2.9×	17	1.3k
Nataša Kuštrimović Serbia	16	273 0.5×	273 0.7×	247 0.9×	134 0.5×	197 0.9×	34	807
Gregory P. Williams United States	10	473 0.8×	434 1.2×	243 0.9×	151 0.6×	181 0.9×	13	745
Alexandra Litvinchuk United States	7	689 1.2×	90 0.2×	158 0.6×	480 2.0×	283 1.4×	8	1.1k
Aubrey M. Schonhoff United States	8	401 0.7×	395 1.1×	219 0.8×	147 0.6×	188 0.9×	8	685

Countries citing papers authored by Katherine E. Olson

Since Specialization

Citations

This map shows the geographic impact of Katherine E. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Olson more than expected).

Fields of papers citing papers by Katherine E. Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Olson. The network helps show where Katherine E. Olson may publish in the future.

Co-authorship network of co-authors of Katherine E. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E. Olson. A scholar is included among the top collaborators of Katherine E. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E. Olson. Katherine E. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olson, Katherine E., Mai Mohamed Abdelmoaty, Krista L. Namminga, et al.. (2023). An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers. Translational Neurodegeneration. 12(1). 26–26. 16 indexed citations

Yeapuri, Pravin, Jatin Machhi, Yaman Lu, et al.. (2023). Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice. Molecular Neurodegeneration. 18(1). 97–97. 36 indexed citations

Yeapuri, Pravin, Katherine E. Olson, Yaman Lu, et al.. (2022). Development of an extended half-life GM-CSF fusion protein for Parkinson's disease. Journal of Controlled Release. 348. 951–965. 19 indexed citations

Marković, Milica, et al.. (2022). Therapeutic Strategies for Immune Transformation in Parkinson’s Disease. Journal of Parkinson s Disease. 12(s1). S201–S222. 19 indexed citations

Abdelmoaty, Mai Mohamed, Pravin Yeapuri, Jatin Machhi, et al.. (2021). Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions. Frontiers in Immunology. 12. 741502–741502. 30 indexed citations

Machhi, Jatin, Pravin Yeapuri, Yaman Lu, et al.. (2021). CD4+ effector T cells accelerate Alzheimer’s disease in mice. Journal of Neuroinflammation. 18(1). 272–272. 96 indexed citations

Olson, Katherine E., Krista L. Namminga, Yaman Lu, et al.. (2021). Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease. Biomaterials. 272. 120786–120786. 38 indexed citations

Dash, Prasanta K., Santhi Gorantla, Larisa Y. Poluektova, et al.. (2021). Humanized Mice for Infectious and Neurodegenerative disorders. Retrovirology. 18(1). 13–13. 21 indexed citations

Olson, Katherine E., Krista L. Namminga, Yaman Lu, et al.. (2021). Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease. EBioMedicine. 67. 103380–103380. 35 indexed citations

10.

Machhi, Jatin, Bhavesh D. Kevadiya, Jonathan Herskovitz, et al.. (2020). Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Molecular Neurodegeneration. 15(1). 32–32. 84 indexed citations

11.

Schwab, Aaron, Jatin Machhi, Katherine E. Olson, et al.. (2020). Immunotherapy for Parkinson’s disease. Neurobiology of Disease. 137. 104760–104760. 68 indexed citations

12.

Olson, Katherine E., Krista L. Namminga, Aaron Schwab, et al.. (2020). Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice. Neurotherapeutics. 17(4). 1861–1877. 25 indexed citations

13.

Loewen, Gordon, Peter A. LeWitt, Karl Kieburtz, et al.. (2019). Pharmacokinetics of Opicapone and Effect on Comt and Levodopa Pharmacokinetics in Patients with Parkinson's Disease. 34. 2 indexed citations

14.

Olson, Katherine E., Aditya N. Bade, Krista L. Namminga, et al.. (2018). Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice. Journal of NeuroVirology. 24(4). 398–410. 14 indexed citations

15.

Gendelman, Howard E., Yuning Zhang, Pamela M. Santamaria, et al.. (2017). Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial. npj Parkinson s Disease. 3(1). 10–10. 107 indexed citations

16.

Olson, Katherine E., Aditya N. Bade, Charles R. Schutt, et al.. (2016). Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease. Neurotherapeutics. 13(3). 635–646. 18 indexed citations

17.

Olson, Katherine E. & Howard E. Gendelman. (2015). Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease. Current Opinion in Pharmacology. 26. 87–95. 49 indexed citations

18.

Skinner, Pamela J., Damani N. Bryant, Cavan Reilly, et al.. (2015). Treatment of Prion Disease with Heterologous Prion Proteins. PLoS ONE. 10(7). e0131993–e0131993. 12 indexed citations

19.

Olson, Katherine E., et al.. (2014). Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders. Translational Neurodegeneration. 3(1). 25–25. 67 indexed citations

20.

Kosloski, Lisa M., Elizabeth A. Kosmacek, Katherine E. Olson, R. Lee Mosley, & Howard E. Gendelman. (2013). GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice. Journal of Neuroimmunology. 265(1-2). 1–10. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact